Zobrazeno 1 - 10
of 87
pro vyhledávání: '"Jean M Elwing"'
Autor:
Sandeep Sahay, Vijay Balasubramanian, Humna Memon, Abby Poms, Eduardo Bossone, Kristine Highland, Dana Kay, Deborah J Levine, Christopher J Mullin, Lana Melendres‐Groves, Stephen C Mathai, Francisco J Soto, Oksana Shlobin, Jean M Elwing
Publikováno v:
Pulmonary Circulation, Vol 12, Iss 2, Pp n/a-n/a (2022)
Abstract Pulmonary arterial hypertension (PAH) is a chronically progressive fatal disease. A goal‐oriented approach to achieve low risk status has been associated with improved survival. A variety of risk stratification tools are available, but use
Externí odkaz:
https://doaj.org/article/10dc882d91c940ca9de32b077a366fb3
Publikováno v:
SAGE Open Medical Case Reports, Vol 4 (2016)
Objective: Anti–N-methyl- d -aspartate receptor encephalitis is a rare but emerging cause of autoimmune encephalitis. Our objective is to present a case of this rare disease while highlighting the importance of an aggressive search for underlying m
Externí odkaz:
https://doaj.org/article/dcc5ccb1b60b4d9aaac4055485e3a0c3
Autor:
Arun Jose, Natalia Rahman, Alexander R. Opotowsky, Thomas J. Glorioso, Stephen W. Waldo, Katarina Zeder, Arnold Seto, Jean M. Elwing, Francis X. McCormack, Bradley A. Maron
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 8 (2024)
Background Portopulmonary hypertension (PoPH), associated with increased mortality, can limit treatment options for liver diseases. Data on the continuum of clinical risk related to cardiopulmonary hemodynamics in PoPH are lacking. Methods and Result
Externí odkaz:
https://doaj.org/article/1ce38369721842aea7debe9d8e7b5a8f
Autor:
Arun Jose, Jean M. Elwing, Steven M. Kawut, Michael W. Pauciulo, Kenneth E. Sherman, William C. Nichols, Michael B. Fallon, Francis X. McCormack
Publikováno v:
Communications Biology, Vol 6, Iss 1, Pp 1-13 (2023)
Abstract Portopulmonary hypertension (PoPH) is a type of pulmonary vascular disease due to portal hypertension that exhibits high morbidity and mortality. The mechanisms driving disease are unknown, and transcriptional characteristics unique to the P
Externí odkaz:
https://doaj.org/article/3f66553713d04b82baf7ae63a140a0fa
Autor:
John F. Kingrey, Chad E. Miller, Veronica Franco, Jimmy S. Smith, Ronald Zolty, Ronald J. Oudiz, Jean M. Elwing, Jessica H. Huston, Lana Melendres‐Groves, Ashwin Ravichandran, Vijay Balasubramanian, Benjamin Wu, Stephanie Hwang, Scott Seaman, Meredith Broderick, Franck F. Rahaghi
Publikováno v:
Pulmonary Circulation, Vol 13, Iss 3, Pp n/a-n/a (2023)
Abstract Treprostinil is a prostacyclin analogue that targets multiple cellular receptors to treat pulmonary arterial hypertension (PAH). In certain scenarios, patients may require aggressive treprostinil titration. Several studies have demonstrated
Externí odkaz:
https://doaj.org/article/d6713b63cd6d420b8006852a2ff0d1ad
Autor:
Paul Forfia, Raymond Benza, Michele D'Alto, Teresa De Marco, Jean M. Elwing, Robert Frantz, Francois Haddad, Ronald Oudiz, Ioana R. Preston, Stephan Rosenkranz, John Ryan, Robert Schilz, Oksana A. Shlobin, Jean‐Luc Vachiery, Carmine Dario Vizza, Anton Vonk Noordegraaf, Margaret R. Sketch, Meredith Broderick, Vallerie McLaughlin
Publikováno v:
Pulmonary Circulation, Vol 13, Iss 2, Pp n/a-n/a (2023)
Abstract Right heart (RH) structure and function are major determinants of symptoms and prognosis in pulmonary arterial hypertension (PAH). RH imaging provides detailed information, but evidence and guidelines on the use of RH imaging in treatment de
Externí odkaz:
https://doaj.org/article/ce8abfb9f6ab4b669e83e51505d50fe2
Autor:
Jacob DeBerry, Parth Rali, Michael McDaniel, Christopher Kabrhel, Rachel Rosovsky, Roman Melamed, Oren Friedman, Jean M. Elwing, Vijay Balasubramanian, Sandeep Sahay, Eduardo Bossone, Mary Jo S. Farmer, Andrew J. P. Klein, Megan E. Hamm, Charles B. Ross, Belinda N. Rivera-Lebron
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
BackgroundInterhospital transfer (IHT) of patients with acute life-threatening pulmonary embolism (PE) is necessary to facilitate specialized care and access to advanced therapies. Our goal was to understand what barriers and facilitators may exist d
Externí odkaz:
https://doaj.org/article/75aab6db92144cddab7123221e778e61
Autor:
Enrico de Belen, John W. McConnell, Jean M. Elwing, David Paculdo, Ian Cabaluna, Jörg Linder, John W. Peabody
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 2 (2023)
Background Diagnosis of pulmonary hypertension (PH) is often delayed or missed, leading to disease progression and missed treatment opportunities. In this study, we measured variation in care provided by board‐certified cardiologists and pulmonolog
Externí odkaz:
https://doaj.org/article/cad3154eeda147b18bd0b88414a89828
Publikováno v:
Heart & Lung. 58:34-38
Patients suffering from pulmonary arterial hypertension (PAH) demand frequent assessment to keep pace with a dynamic and sometimes rapidly progressive disease course. To improve our understanding of patient monitoring, we conducted a survey of pulmon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5cf1f7f2da5336f97423ee723ff7e91
https://doi.org/10.1016/j.hrtlng.2022.10.016
https://doi.org/10.1016/j.hrtlng.2022.10.016
Publikováno v:
Pulmonary Circulation, Vol 9 (2019)
Systemic anticoagulation may be beneficial in pulmonary arterial hypertension, but there is no randomized clinical trial data to guide therapeutic decision making, and current guidelines do not account for patient preferences or quality of life. Deci
Externí odkaz:
https://doaj.org/article/21b15453f95b4b6f9a8f51d227048000